Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:30 PM
Ignite Modification Date:
2025-12-24 @ 4:30 PM
NCT ID:
NCT01021566
Eligibility Criteria:
Inclusion Criteria:
* Be fulfilled DSM-IV criteria(American Psychiatric Association) for opiate dependence.
* A history of current dependence on heroin, which was supported by laboratory results from urine drug screening, using both chromatographic and radioimmunoassay methods.
* Opioid dependent patients who inject heroin from 0.5g to 1.0g daily by veins for at least 1 year.
* Haven't received methadone treatment for at least 2 months before entry to this study.
* Be able to understand and have signed the informed consent.
Exclusion Criteria:
* Take heroin for the first time.
* Positive for HIV.
* The function of cruor or hemorrhage is badly damaged.
* The number of platelets is lower than 70×10\*9.
* Co-dependent on substances other than opiates (including alcohol, benzodiazepines, cocaine, or amphetamines).
* Methadone dose requirement is over 70 mg/day as determined by the 3-day dose assessment period.
* Have serious physical illness or major psychiatric illness.
* Pregnant woman.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
45 Years
Study:
NCT01021566
Study Brief:
Protocol Section:
NCT01021566